Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoietin ausschließlich Epoetin alfa, ATC B03XA01 für die Zeit 01.03.2025 - 28.02.2027
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- Abacus Medicine A/S, axicorp Pharma GmbH, CC Pharma GmbH, EMRA-MED Arzneimittel GmbH, EurimPharm Arzneimittel GmbH, HEXAL AG, kohlpharma GmbH, MEDICE Arzneimittel Pütter GmbH & Co KG, RiePharm GmbH
- Contract value
- no value published
- Bids received
- 12
- Published
- 2 Jul 2026
- Awarded
- 1 Mar 2025
- Contract start
- 1 Mar 2025
- Contract end
- 14 Mar 2026estimated
- Region
- Hamburg